<DOC>
	<DOC>NCT00316121</DOC>
	<brief_summary>The purpose of this study is to determine the safety and effectiveness of HEALOS compared with autograft using the transforaminal lumbar interbody fusion (TLIF) method.</brief_summary>
	<brief_title>Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Persistent back and/or leg pain refractory to 6 months of nonsurgical therapy Male or female 18 to 70 years of age (inclusive) Objective evidence of significant disc degeneration at one or two adjacent lumbar level(s) from L2/L3 to L5/S1 Significant disc degeneration at more than two adjacent levels Greater than Grade II spondylolisthesis Prior fusion surgery of the lumbar spine (prior discectomies and intradiscal electrothermal therapy [IDET] are allowed) Insulindependent diabetes mellitus Pregnant or lactating, or wishes to become pregnant within the 24 month duration of the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>One or Two Level Degenerative Disc Disease</keyword>
</DOC>